Cavinton (Vinpocetine) 5 mg/ml, 10 ampoules

Cavinton (Vinpocetine) 5 mg/ml — 10 Ampoules × 5 ml, Gedeon Richter

Cavinton by Gedeon Richter is the original vinpocetine injectable - a cerebral circulation enhancer derived from the periwinkle plant alkaloid. It selectively dilates brain vessels without the "steal effect" (blood redistribution away from damaged areas), improving oxygen and glucose delivery exactly where metabolism is impaired.

Composition

• Vinpocetine - 5 mg/ml (25 mg per 5 ml ampoule)
• Pack: 10 ampoules × 5 ml
• Excipients: ascorbic acid, sodium metabisulfite, tartaric acid, water for injection

Why vinpocetine is different

Classic vasodilators can worsen ischemia by redirecting blood to healthy vessels ("steal phenomenon"). Vinpocetine acts selectively: it enhances cerebral blood flow preferentially in underperfused areas, reduces platelet aggregation and improves red blood cell deformability. This selectivity is why neurologists keep it in stroke-recovery protocols for decades.

Where Cavinton is used

• Acute phase of stroke (in combination therapy) and stroke recovery
• Chronic cerebral circulation insufficiency: dizziness, headaches, memory decline
• Vascular cognitive impairment
• Vertebrobasilar insufficiency and post-traumatic cerebral disorders

Administration (per instructions)

• IV drip only: dilute the ampoule in 500 ml of 0.9% sodium chloride; start at 20 mg/day, if tolerated increase to 1 mg/kg/day (max 3 ampoules)
• Never administer undiluted intramuscularly or as IV jet - the solution is for drip infusion only
• Course: 10-14 days IV, then transition to oral Cavinton tablets for continuation
• Administered by medical personnel in clinical settings

Product features

• Original Gedeon Richter product (Hungary/EU)
• Ready-to-dilute solution
• Decades of neurological use - one of the most studied cerebral vasodilators

Contraindications

Hypersensitivity to vinpocetine or components; severe cardiac arrhythmias; acute hemorrhagic phase of stroke; pregnancy and breastfeeding. IV administration in medical settings only.

FAQ

Cavinton injections or tablets?

The classic scheme: 10-14 days IV drip in clinic (this product), then 1-3 months oral tablets for consolidation. Injections are for the acute phase; tablets maintain the result.

What is the "steal effect" and why does it matter?

Generic vasodilators widen all vessels - blood flows to healthy areas while damaged zones stay deprived. Vinpocetine works preferentially where perfusion is already low - that is the pharmacological reason for its stroke-recovery role.

Why must it be diluted in 500 ml?

Vinpocetine requires slow delivery: the drip format over hours prevents blood pressure drops. This is a manufacturer requirement, not a preference.

Can it be combined with Actovegin or Cortexin?

Yes - the classic post-stroke trio combines a circulation enhancer (Cavinton), a metabolic corrector (Actovegin) and a neuroprotector (Cortexin). The exact scheme is set by the neurologist.

When do patients feel the effect?

Dizziness and headache relief often appear within the first days of the course; cognitive benefits build over weeks of combined oral therapy.

Ask a question or inquire about delivery to your country

Telegram

WhatsApp